Filling the Funding Gap to Save Lives
|
|
- Eustace Quinn
- 5 years ago
- Views:
Transcription
1 Filling the Funding Gap to Save Lives A Proposal for an Equitable Contributions Framework for the Global Fund 1 October 9, 2002, Global Day of Action on the Global Fund "To succeed, the amount of money spent must be dramatically increased Many billions more will be required quickly to implement the high-quality proposals that we anticipate receiving during the next twelve months." Richard Feachem, Executive Director, Global Fund to Fight AIDS, TB, and Malaria, July 2002 Without treatment, the 28 million people living with HIV/AIDS (PLWAs) on our continent today will die predictable and avoidable deaths over the next decade. More than 2 million have died of HIV/AIDS in Africa just this year. This constitutes a crime against humanity.we demand that Donor Countries (members of the Organization of Economic Development and Cooperation or OECD and middle-income countries): Fulfill existing commitments to adequately fund the Global Fund to Fight AIDS, Tuberculosis and Malaria and other HIV/AIDS financing mechanisms with at least $10 billion of new funding annually as a proportion of GDP Pan-African HIV/AIDS Treatment Access Movement, Declaration Of Action, Cape Town, South Africa, 25 August This report was primarily drafted for the Global AIDS Alliance by Bernard Rivers of Aidspan, a nonprofit organization that conducts economic analysis regarding AIDS and that provides grant-writing assistance to developing-country AIDS projects. A downloadable version of the report is available at and at Comments were provided by Joanne Carter of RESULTS and David Bryden and Paul Zeitz of the Global AIDS Alliance. Global AIDS Alliance, PO Box 820, Bethesda, MD Tel
2 Introduction Three months ago, a sobering report by UNAIDS warned that contrary to earlier expectations, the incidence of AIDS is still climbing even in the worst affected countries. Nearly 70 million people will die because of AIDS in the 45 most affected countries over the next 20 years, more than five times the number claimed by AIDS in those same countries during the past 20 years. In some countries, AIDS will kill half the women who became mothers in recent years, thereby creating countless more orphans. Then just a few days ago, the National Intelligence Council predicted that by 2010 there will be 50 to 75 million cases of HIV infection in just five nations which it deemed of strategic importance to the US, none of them in Southern Africa India, China, Ethiopia, Nigeria and Russia. That is double or triple the estimate of 25 million cases an international team of experts projected for those countries as part of a study published last summer. The new intelligence estimate states Nigeria and Ethiopia will be worst affected, because AIDS will take a heavy economic toll and discourage foreign investment. Treatment methods for AIDS are available, but do not reach the people who need them. In high-income countries, 500,000 people received antiretroviral treatment in 2001, which made it possible to keep deaths down to 25,000. But in Africa, a mere 30,000 people received such treatment, dooming a staggering 2,200,000 to die of AIDS in 2001 alone. The contrast between these two situations can only be described as obscene. The two other leading infectious diseases are tuberculosis and malaria. TB kills two million people a year. One-third of the world s population is infected with the organism that causes TB. While TB is completely curable with drugs to treat standard TB costing just $10 for a full sixmonth course only one quarter of those with active TB have access to effective treatment. Incorrect or partial treatment leads to the development of dangerous multi-drug-resistant tuberculosis. Malaria kills nearly a million people each year, most of them children, primarily in Africa. Some 300 million people are made sick by malaria each year. The great majority of the deaths could be prevented with drugs costing a few pennies. Insecticide-treated bednets costing around $4 can prevent infection. Filling the Funding Gap to Save Lives 1
3 The Importance of the Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM) Effective bilateral support by high-income countries for programs to tackle these three diseases will always be needed. But a new and potentially highly effective channel was put in place at the start of this year, and this needs to be much more firmly supported than it has been thus far. That channel is the Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM). The GFATM is not a UN agency. It is controlled by an innovative board made up of donor countries, recipient countries, and representatives of civil society, foundations and corporations. For the fight against AIDS to succeed, the GFATM must be fully supported. As a result of its creative design, the Fund is uniquely positioned: to galvanize much greater contributions from the world community for the fight against AIDS, TB and malaria; to handle in a streamlined way the substantial amounts of money needed to finance effective programs, thereby leading to efficiencies and economies of scale; to be far more transparent and accountable than most bilateral aid is, thereby reducing the risk of inappropriate donor agendas, and of graft and corruption anywhere along the giving chain; to provide multi-year grants that make grantees willing to commence antiretroviral treatment and other programs without fear of termination of funding after a year or two; to bring together governments, non-governmental groups and the private sector within affected countries, and to require them to work together to develop and implement effective proposals; to track the outcomes achieved by funded programs, and to make the receipt of payment for the later years of programs be dependent upon evidence that the planned outcomes are being achieved and that numerous people are obtaining access to treatment and prevention. How Much Money Should be Spent by the World Community on AIDS, TB and Malaria? The World Health Organization s Commission on Macroeconomics and Health (CMH), chaired by Prof. Jeffrey Sachs, estimated late last year as follows: Expenditure on health in 85 low- and middle-income countries needs to increase from about $106 billion in 2002 to $168 billion in This increase in expenditure will save some 8 million lives per annum, and will lead to economic returns significantly greater than the health expenditure required. Of the required $168 billion health expenditure in 2007, $141 billion could be covered from the domestic resources of the affected countries. Filling the Funding Gap to Save Lives 2
4 Thus, the financing gap that needs to be covered through additional donor aid comes to $27 billion in Of this, some $15-17 billion needs to be applied to HIV/AIDS, TB and malaria in Necessary Funding of the Global Fund to Fight AIDS, TB, and Malaria The above calculations were made before the GFATM began its work at the start of this year. In January, the GFATM invited governments and civil society in affected countries to create joint committees called Country Coordination Mechanisms (CCMs) to formulate and submit grant proposals to the GFATM, and to administer the grants received in those cases where the proposals were approved. In April of this year, the GFATM announced Round 1 of its grants. Fifty-eight of the 331 proposals received were approved. These approved proposals had funding requirements of $283 million in the first year, building up to a total of $616 over the first two years and $1,613 million over five years. On October 10-11, the GFATM board will vote on whether to approve and release a Financial Prospectus that spells out the Fund s forthcoming financial needs. The Global AIDS Alliance has obtained a copy of this document. As summarized in Table 1, below, the Financial Prospectus shows that: In 2003, the GFATM will need to receive $4,250 m., of which only $650 m. has been pledged thus far. (The $4,250 m. will be to cover anticipated commitments regarding Years 1 and 2 of grants in Rounds 2, 3 and 4.) In 2004, the GFATM will need to receive a further $4,600 m., of which only $300 m. has been pledged thus far. (This will be to cover anticipated commitments regarding Years 3 to 5 of Round 1, plus Years 1 and 2 of grants in Rounds 5 and 6.) This data makes clear that the Fund faces a severe financial shortfall. If this shortfall is not rectified, there will be a failure of many programs that depend upon regular replenishment, including programs that provide medication for sustaining life and preventing HIV transmission. Table 1: Contributions Needed by the GFATM, and Pledges Received Thus Far Year Cash that the GFATM says it needs to receive from donors during the years shown Total needed Pledged thus far 2 Thus, new pledges needed 2003 $4,250 m. $650 m. $3,600 m $4,600 m. $300 m. $4,300 m. 2 Numbers rounded to nearest $10 m. Pledge data, which is as of 1 October 2002, assumes that $318 m. in pledges where the payment year was not specified by the donor is spread evenly over 2002 to Filling the Funding Gap to Save Lives 3
5 A Proposed New Approach: The Equitable Contributions Framework Thus far, efforts have been made to raise the money needed by the GFATM through ad hoc voluntary donations. These efforts have been a complete and unconscionable failure. Governments have pledged a mere $2.1 billion spread over the years 2001 through (Contributions from the private sector have been even more disappointing, with not a single meaningful pledge since the Bill & Melinda Gates Foundation offered $100 million over a year ago.) Based upon these initial pledges, the GFATM will be unable to make the commitments it needs to when it approves Round 2 of grants in January It s time for a new approach. The only way in which the GFATM can raise billions of dollars every year is if contributions to the GFATM are equitably shared among the countries whose citizens live the most comfortable and unthreatened lives. This means that the wealthiest countries particularly the G7 countries need to contribute considerably more than they currently do. But it also means that contributions should come from other relatively wealthy countries, such as Australia, that have as yet contributed nothing. The Global AIDS Alliance therefore proposes that contributions to the GFATM should be computed according to an Equitable Contributions Framework, leading to complete clarity regarding how much each country should contribute now that the total amount that needs to be raised has been determined by the GFATM. The Equitable Contributions Framework is as follows: Ninety percent of the contributions required by the GFATM should be provided by the 47 countries that have a high Human Development Index, or HDI. (The HDI measures the overall quality of life based on standard of living, life expectancy, and literacy plus school-enrolment.) The contributions to be paid by these 47 countries should be in proportion to their respective GDPs. The remaining 10% of the GFATM s needs should be contributed by the private sector (foundations, corporations, wealthy individuals, and members of the public), thereby making the GFATM a true public/private partnership at the donor end, not just at the recipient end. Filling the Funding Gap to Save Lives 4
6 Application of the Equitable Contributions Framework to the GFATM requirements specified in Table 1 leads to the following: Donors Table 2: An Equitable Contributions Framework for the GFATM % of total obligation to GFATM that we propose be payable by each donor (proportionate to GDP) Thus, money that needs to be RECEIVED by the GFATM from each donor during: Pledged Percent of thus far by GDP that each donor this 2003 for pledge payment in represents The G7 high Human Development Index 73.5% $3,145 m. $3,404 m. $447 m % countries: United States 34.8% $1,488 m. $1,610 m. $200 m % Japan 16.5% $704 m. $762 m. $0 m. 0% Germany 6.6% $282 m. $305 m. $34 m % United Kingdom 5.0% $213 m. $230 m. $39 m % France 4.5% $194 m. $210 m. $49 m % Italy 3.8% $161 m. $174 m. $100 m % Canada 2.4% $104 m. $112 m. $25 m % The 40 non-g7 high Human Development Index countries (See Appendix): 16.5% $680 m. $736 m. $84 m % Total for all 47 high HDI countries: 90.0% $3,825 m. $4,140 m. $531 m % Other: $69 m. 4 Private sector 10.0% $425 m. $460 m. $50 m. Total (equal to GFATM s requirements): 100.0% $4,250 m. $4,600 m. $650 m. Implications for the United States The amount that the United States has pledged to the GFATM thus far for 2003 at % of GDP is significantly less than the percentages pledged by G7 countries Italy (0.0047%), France (0.0019%), Canada (0.0018%), and UK (0.0014%). In recent weeks, Committees of the US House and Senate approved increasing the US pledge to the Fund for fiscal year 2003 from $200 million to $250 million (House version) or $300 million (Senate version). With the United States appropriations process currently stalled, these amounts have not yet received full approval from either legislative body, and further increases, absent Presidential leadership, remain unlikely. 3 Pledge data is as of 1 October Russia ($4 m.), Thailand ($1 m.), plus one fifth of the $318 m. in pledges that was not assigned by donors to a specific year. Filling the Funding Gap to Save Lives 5
7 To be a global leader in combating this epidemic, it s high time the US paid its fair share. This requires it to increase its contribution to the GFATM from $200 m. to $1,488 m. for 2003, and to contribute a further $1,610 m. during President Bush should use the opportunity of his upcoming trip to Africa, in January 2003, to make providing such contributions a key part of a broad initiative on global AIDS. Implications for the Rest of the G7 Based on this analysis, other G7 countries should also immediately pledge and provide a much higher level of contributions to the Global Fund in order to forestall a shortfall in Fund resources. After the US, Japan is the furthest away from paying at a level corresponding to what this analysis shows would be an equitable contribution; it should dramatically increase its contributions for 2003, to $704 million. Germany, the United Kingdom, France, and Canada should also each immediately increase their contributions, by $248, $174, $145, and $79 million, respectively. Italy is the closest to having made an equitable pledge for 2003, having pledged $100 million toward what would be an appropriate level of $161 million, but it must also increase its donations. Filling the Funding Gap to Save Lives 6
8 Appendix: Details for Table 2 regarding the 40 non-g7 high Human Development Index countries Donors % of total obligation to GFATM that we propose be payable by each donor Thus, money that needs to be RECEIVED by the GFATM from each donor during: (proportionate to GDP) Pledged thus far by each donor for payment in 2003 Percent of GDP that this 2003 pledge represents The 40 non-g7 high Human Development Index countries: 16.5% $680 m. $736 m. $84 m % Spain 1.97% $84 m. $90 m. South Korea 1.62% $69 m. $75 m. Australia 1.40% $59 m. $64 m. Netherlands 1.29% $55 m. $59 m. $44 m % Argentina 1.01% $43 m. $47 m. Switzerland 0.85% $36 m. $39 m. $5 m % Belgium 0.82% $35 m. $38 m. $6 m % Sweden 0.81% $34 m. $37 m. $29 m % Austria 0.68% $29 m. $31 m. Denmark 0.57% $24 m. $26 m. Poland 0.56% $24 m. $26 m. Norway 0.53% $22 m. $24 m. Finland 0.42% $18 m. $20 m. Greece 0.40% $17 m. $18 m. Israel 0.39% $17 m. $18 m. Portugal 0.37% $16 m. $17 m. Ireland 0.33% $14 m. $15 m. Singapore 0.33% $14 m. $15 m. Chile 0.25% $11 m. $12 m. New Zealand 0.18% $8 m. $8 m. Czech Republic 0.18% $7 m. $8 m. United Arab Emirates 0.16% $7 m. $8 m. Hungary 0.16% $7 m. $7 m. Kuwait 0.11% $4 m. $5 m. Uruguay 0.07% $3 m. $3 m. Slovakia 0.07% $3 m. $3 m. Croatia 0.07% $3 m. $3 m. Luxembourg 0.07% $3 m. $3 m. $1 m % Slovenia 0.06% $3 m. $3 m. Costa Rica 0.06% $2 m. $3 m. Qatar 0.04% $2 m. $2 m. Lithuania 0.04% $2 m. $2 m. Cyprus 0.03% $1 m. $1 m. Iceland 0.03% $1 m. $1 m. Bahrain 0.02% $1 m. $1 m. Estonia 0.02% $1 m. $1 m. Brunei 0.02% $1 m. $1 m. Bahamas 0.02% $1 m. $1 m. Malta 0.01% $1 m. $1 m. Barbados 0.01% $1 m. $1 m. Filling the Funding Gap to Save Lives 7
Donor Government Funding for HIV in Low- and Middle-Income Countries in 2016
REPORT Donor Government Funding for HIV in Low- and Middle-Income Countries in 2016 July 2017 Prepared by: Jen Kates & Adam Wexler Kaiser Family Foundation and Eric Lief Consultant and UNAIDS Donor government
More informationFinancing the Response to AIDS in Low- and Middle- Income Countries: International Assistance from Donor Governments in 2011
Financing the Response to AIDS in Low- and Middle- Income Countries: International Assistance from Donor Governments in 2011 Authors: Jennifer Kates (Kaiser Family Foundation), Adam Wexler (Kaiser Family
More informationAuthors: Jennifer Kates (Kaiser Family Foundation), José-Antonio Izazola (UNAIDS), Eric Lief (CSIS).
Financing the response to AIDS in low- and middleincome countries: International assistance from the G8, European Commission and other donor Governments, 2006 Authors: Jennifer Kates (Kaiser Family Foundation),
More informationKey Highlights continued
Financing the Response to AIDS in Low- and Middle- Income Countries: International Assistance from the G8, European Commission and Other Donor Governments in 2009 Authors: Jennifer Kates (Kaiser Family
More informationDonor Government Funding for HIV in Low- and Middle-Income Countries in 2017
July 2018 Donor Government Funding for HIV in Low- and Middle-Income Countries in 2017 Jen Kates & Adam Wexler Kaiser Family Foundation and Eric Lief Georgetown University, Center for Global Health Science
More informationFinancing the Response to AIDS in Low- and Middle- Income Countries: International Assistance from Donor Governments in 2010
Financing the Response to AIDS in Low- and Middle- Income Countries: International Assistance from Donor Governments in 2010 Authors: Jennifer Kates (Kaiser Family Foundation), Adam Wexler (Kaiser Family
More informationAuthors: Jennifer Kates (Kaiser Family Foundation), Eric Lief (The Stimson Center), Carlos Avila (UNAIDS).
Financing the response to AIDS in low- and middleincome countries: International assistance from the G8, European Commission and other donor Governments in 2008 Authors: Jennifer Kates (Kaiser Family Foundation),
More informationFinancing the Response to HIV/AIDS in Low and Middle Income Countries: Funding for HIV/AIDS from the G7 and the European Commission
Financing the Response to HIV/AIDS in Low and Middle Income Countries: Funding for HIV/AIDS from the G7 and the European Commission Presented at: Post G8 Briefing: Future Financing To Address The Global
More informationReflecting on ten years of progress in the fight against AIDS, TB and malaria
Reflecting on ten years of progress in the fight against AIDS, TB and malaria Michel Kazatchkine UN Secretary General s Special Envoy on HIV/AIDS in Eastern Europe and central Asia Ten years of progress:
More informationIOSH No Time to Lose campaign: working together to tackle asbestos-related cancer #NTTLasbestos. Jonathan Hughes IOSH Vice President
IOSH No Time to Lose campaign: working together to tackle asbestos-related cancer #NTTLasbestos Jonathan Hughes IOSH Vice President About the Institution of Occupational Safety and Health (IOSH) www.iosh.co.uk
More informationThe health economic landscape of cancer in Europe
1 Approval number The health economic landscape of cancer in Europe Bengt Jönsson, Professor Emeritus of Health Economics Stockholm School of Economics 2 Disclaimer This presentation was developed by Professor
More informationFinancial Resources for HIV: PEPFAR s Contributions to the Global Scale-up of Treatment
Financial Resources for HIV: PEPFAR s Contributions to the Global Scale-up of Treatment Joint WHO & UNAIDS Consultation with Pharmaceuticals and Stakeholders November 05 2012 Lara Stabinski, MD, MPH Medical
More informationGlobal EHS Resource Center
Global EHS Resource Center Understand environmental and workplace safety requirements that affect your global operations. 800.372.1033 bna.com/gelw Global EHS Resource Center This comprehensive research
More informationD7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells
Disclaimer: The content of this Deliverable represents the views of the author only and is his/her sole responsibility; it cannot be considered to reflect the views of the European Commission and/or the
More informationD7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells
Disclaimer: The content of this Deliverable represents the views of the author only and is his/her sole responsibility; it cannot be considered to reflect the views of the European Commission and/or the
More informationMain developments in past 24 hours
ECDC DAILY UPDATE Pandemic (H1N1) 2009 Update 02 October 2009, 09:00 hours CEST Main developments in past 24 hours Weekly Influenza Surveillance Overview to be published today; Media highlights and Eurosurveillance
More informationWCPT COUNTRY PROFILE December 2017 SWEDEN
WCPT COUNTRY PROFILE December 2017 SWEDEN SWEDEN NUMBERS WCPT Members Practising physical therapists 11,043 Total number of physical therapist members in your member organisation 17,906 Total number of
More informationTerms and Conditions. VISA Global Customer Assistance Services
Terms and Conditions VISA Global Customer Assistance Services Visa Global Customer Assistance Services (VGCAS) 1 The Visa Global Customer Assistance Services are co-ordinated by the Global Assistance Centre
More informationSmokefree Policies in Europe: Are we there yet?
Smokefree Policies in Europe: Are we there yet? 14 April 2015, 9:00 10:30am Rue de l Industrie 24, 1040 Brussels Permanent Partners: Temporary Partners: The research for the SFP Smokefree Map was partially
More information1. Global Fund on HIV/AIDS, Tuberculosis and Malaria
1. Global Fund on HIV/AIDS, Tuberculosis and Malaria Commitment We will work with other donors and stakeholders in the effort to secure funds needed for the 2006-2007 replenishment period and call upon
More informationGlobal Funding for HIV/AIDS in Resource Poor Settings
Global Funding for HIV/AIDS in Resource Poor Settings Todd Summers Progressive Health Partners Jennifer Kates Kaiser Family Foundation December 2003 Global Funding for HIV/AIDS in Resource Poor Settings
More informationWorld Connections Committee (WCC) Report
World Connections Committee (WCC) Report 06 Co-Dependents Anonymous Service Conference Countries Where CoDA Exists This report reflects the World Connections Committee (WCC) support of the growth and development
More informationWCPT COUNTRY PROFILE December 2017 HUNGARY
WCPT COUNTRY PROFILE December 2017 HUNGARY HUNGARY NUMBERS WCPT Members Practising physical therapists 727 Total number of physical therapist members in your member organisation 4,000 Total number of practising
More informationPharmaceutical, Medical and Health-related Government and Regulatory bodies around the world.
1 International International Conference on Harmonization (ICH) World Health Organization (WHO) 2 Argentina National Administration of Drugs, Food and medical Technology. Australia s Department of health
More informationPROMOTION AND PROTECTION OF ALL HUMAN RIGHTS, CIVIL, POLITICAL, ECONOMIC, SOCIAL AND CULTURAL RIGHTS, INCLUDING THE RIGHT TO DEVELOPMENT
UNITED NATIONS A General Assembly Distr. LIMITED A/HRC/11/L.16 16 June 2009 Original: ENGLISH HUMAN RIGHTS COUNCIL Eleventh session Agenda item 3 PROMOTION AND PROTECTION OF ALL HUMAN RIGHTS, CIVIL, POLITICAL,
More informationWCPT COUNTRY PROFILE December 2017 SERBIA
WCPT COUNTRY PROFILE December 2017 SERBIA SERBIA NUMBERS WCPT Members Practising physical therapists 622 Total number of physical therapist members in your member organisation 3,323 Total number of practising
More informationLouisville '19 Attachment #69
Telephone Meeting Approved and why I propose Using zoom to fulfill both Phone and Virtual video meeting Formats. The first established phone meeting Sanctioned by Gamblers Anonymous (listed on Trustee
More informationDEVELOPMENT. The European Union confronts HIV/AIDS, malaria and tuberculosis. A comprehensive strategy for the new millennium EUROPEAN COMMISSION
DEVELOPMENT The European Union confronts HIV/AIDS, malaria and tuberculosis A comprehensive strategy for the new millennium EUROPEAN COMMISSION DE 121 FEB 2004 A global challenge Every minute, 11 people
More information508 the number of suicide deaths in deaths per 100,000 people was the suicide rate in Suicide deaths in 2013 by gender
An overview of suicide statistics This document summarises information about suicide deaths in New Zealand covering up to 13. It does not attempt to explain causes of suicidal behaviour or causes of changes
More informationOverview of development assistance for health trends
Chapter 1 Overview of development assistance for health trends This chapter uses estimates of development assistance for health (DAH) produced by the Institute for Health Metrics and Evaluation (IHME)
More informationAppendix F: Test-Curriculum Matching Analysis
Appendix F: Test-Curriculum Matching Analysis TIMSS went to great lengths to ensure that comparisons of student achievement across countries would be as fair and equitable as possible. The TIMSS 2015 Assessment
More informationESPEN Congress Geneva 2014 FOOD: THE FACTOR RESHAPING THE SIZE OF THE PLANET
ESPEN Congress Geneva 2014 FOOD: THE FACTOR RESHAPING THE SIZE OF THE PLANET Buy 2 and take 3: are we benefitting from cheaper food? P. Marques-Vidal (CH) Pedro Marques-Vidal Department of Internal Medicine
More informationOkinawa, Toyako, and Beyond: Progress on Health and Development
Okinawa, Toyako, and Beyond: Progress on Health and Development Prof. Michel D. Kazatchkine Executive Director The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations University, Tokyo,
More informationAllied Health: Sustainable Integrated Health Care for all Australians
Allied Health: Sustainable Integrated Health Care for all Australians Catherine Turnbull Chief Allied and Scientific Health Advisor SA Health Presentation to Indigenous Allied Health Australia Conference,
More informationTobacco: World Markets and Trade
United States Department of Agriculture Foreign Agricultural Service Circular Series FT -09-05 Sep. 2005 List of Tables Tobacco: World Markets and Trade Table 2 U.S. Tobacco Trade: 2004-2005 Table 3 Unmanufactured
More informationUK bowel cancer care outcomes: A comparison with Europe
UK bowel cancer care outcomes: A comparison with Europe What is bowel cancer? Bowel cancer, which is also known as colorectal or colon cancer, is a cancer that affects either the colon or the rectum. The
More informationSperm donation Oocyte donation. Hong Kong þ Guideline þ þ Hungary þ þ þ þ Israel þ þ þ þ Italy þ þ þ. Germany þ þ þ þ Greece þ þ þ þ
CHAPTER 8: Donation Although there has been a reduction in the use of donor sperm because of ICSI and the impact of the removal of anonymity in some countries (1), sperm donation is still used and has
More informationDevelopment assistance for HIV/AIDS, tuberculosis and malaria by channel
Chapter 6: Distribution of development assistance for health Building a foundation of knowledge that accurately accounts for the volume of global health funding is crucial, both for those who give aid
More informationXDR-TB Extensively Drug-Resistant Tuberculosis. What, Where, How and Action Steps
XDR-TB Extensively Drug-Resistant Tuberculosis What, Where, How and Action Steps The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever
More informationManuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal
Manuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal Public Health Public health is the science and art of preventing disease, prolonging
More informationType 1 Diabetes Australian Research Impact Analysis
Type 1 Diabetes Australian Research Impact Analysis Executive Overview Summary Type 1 diabetes research in Australia Australia is making a significant contribution to the quantity and quality of the global
More informationAppendix F. The Test-Curriculum Matching Analysis Science TIMSS 2011 INTERNATIONAL RESULTS IN SCIENCE APPENDIX F 479
Appendix F The Test-Curriculum Matching Analysis Science TIMSS 2011 INTERNATIONAL RESULTS IN SCIENCE APPENDIX F 479 TIMSS went to great lengths to ensure that comparisons of student achievement across
More informationBio-Rad Laboratories HEMOGLOBIN Testing Bio-Rad A1c. VARIANT II TURBO Link. Fully-Automated HbA 1c Testing
Bio-Rad Laboratories HEMOGLOBIN Testing Bio-Rad A1c VARIANT II TURBO Link Fully-Automated HbA 1c Testing Bio-Rad Laboratories HEMOGLOBIN Testing VARIANT II TURBO Link Efficient streamlined process Powerful
More informationPost-2015: Innovative Financing of HIV/AIDS. Travis Mitchell Economic Affairs Division
Post-2015: Innovative Financing of HIV/AIDS Travis Mitchell Economic Affairs Division High Burden (HIV/AIDS) Low Income countries will remain dependent on external funding for decades, creating major financial
More informationRenewing Momentum in the fight against HIV/AIDS
2011 marks 30 years since the first cases of AIDS were documented and the world has made incredible progress in its efforts to understand, prevent and treat this pandemic. Progress has been particularly
More informationMedia Release. Inaugural study reveals that more than one in four women in European and Central Asian prisons locked up for drug offences
Media Release Embargoed 00.01 CET Monday 12 th March 2012 Inaugural study reveals that more than one in four women in European and Central Asian prisons locked up for drug offences Up to 70 percent of
More informationCross Border Genetic Testing for Rare Diseases
Cross Border Genetic Testing for Rare Diseases EUCERD Joint Action WP8 Helena Kääriäinen National Institute for Health an Welfare, Helsinki, Finland Starting point Possibilities and demand for genetic
More informationREPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS
EUROPEAN COMMISSION Brussels, 17.6.011 COM(011) 35 final REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS
More informationTHE GLOBAL HEALTH SECURITY AGENDA. We have to change our mindsets and start thinking about biological threats as the security threats that they are.
THE GLOBAL HEALTH SECURITY AGENDA We have to change our mindsets and start thinking about biological threats as the security threats that they are. President Barack Obama September 26, 2014 1 Global Health
More informationTHE CARE WE PROMISE FACTS AND FIGURES 2017
THE CARE WE PROMISE FACTS AND FIGURES 2017 2 SOS CHILDREN S VILLAGES INTERNATIONAL WHERE WE WORK Facts and Figures 2017 205 58 79 families and transit 31 Foster homes 162 8 3 173 214 2 115 159 136 148
More information39th SESSION OF THE SUBCOMMITTEE ON PLANNING AND PROGRAMMING OF THE EXECUTIVE COMMITTEE
PAN AMERICAN HEALTH ORGANIZATION WORLD HEALTH ORGANIZATION 39th SESSION OF THE SUBCOMMITTEE ON PLANNING AND PROGRAMMING OF THE EXECUTIVE COMMITTEE Washington, D.C., USA, 16-18 March 2005 Provisional Agenda
More informationMonthly measles and rubella monitoring report
SURVEILLANCE REPORT Monthly measles and rubella monitoring report December 2018 Period covered: 1 November 2017 to 31 October 2018 Introduction This monitoring report is based on measles and rubella data
More informationTHE CVD CHALLENGE IN NORTHERN IRELAND. Together we can save lives and reduce NHS pressures
THE CVD CHALLENGE IN NORTHERN IRELAND Together we can save lives and reduce NHS pressures The challenge of CVD continues today. Around 225,000 people in Northern Ireland live with the burden of cardiovascular
More informationMen & Health Work. Difference can make a difference Steve Boorman & Ian Banks RSPH Academy 2013
Men & Health Promotion @ Work Difference can make a difference Steve Boorman & Ian Banks RSPH Academy 2013 Difference can make a Difference Mens health: State of mens health Use of services Role of the
More informationMonitoring the Declaration of Commitment on HIV/AIDS & UNGASS indicators
Monitoring the Declaration of Commitment on HIV/AIDS & UNGASS indicators José Antonio Izazola Chief, AIDS Financing and Economics Division Evidence, Monitoring and Policy Department UNAIDS Assessment 6.3
More informationAlcohol Prevention Day
Alcohol Prevention Day Rome, 16 May 2018 Hana Horka Policy Officer, Unit C4 Health Determinants and International Relations European Commission DG Health and Food Safety (SANTE) Alcohol consumption in
More informationGLOBAL INVESTMENT IN HIV CURE RESEARCH AND DEVELOPMENT IN 2017 AFTER YEARS OF RAPID GROWTH FUNDING INCREASES SLOW
GLOBAL INVESTMENT IN HIV CURE RESEARCH AND DEVELOPMENT IN 2017 AFTER YEARS OF RAPID GROWTH FUNDING INCREASES SLOW TOWARDS AN CURE PEOPLE FOCUSED SCIENCE DRIVEN JULY 2018 A GLOBAL STRATEGIC APPROACH TOWARDS
More informationBio-Rad Laboratories HEMOGLOBIN Testing Bio-Rad A1c. VARIANT II TURBO Link System. Fully-Automated HbA 1c Testing
Bio-Rad Laboratories HEMOGLOBIN Testing Bio-Rad A1c VARIANT II TURBO Link System Fully-Automated HbA 1c Testing Bio-Rad Laboratories HEMOGLOBIN Testing VARIANT II TURBO Link System Efficient streamlined
More informationThe Global Picture in Blood Transfusions: A Quick Overview
The Global Picture in Blood Transfusions: A Quick Overview Jim MacPherson President & CEO MacPherson Strategies jim@macphersonstrategies.com +1 202 468 6548 24 March 2017 WHO 2016 Of the 113 million blood
More informationCOMMISSION OF THE EUROPEAN COMMUNITIES
COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 22.12.2008 COM(2008) 882 final REPORT FROM THE COMMISSION TO THE COUNCIL, THE EUROPEAN PARLIAMENT, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE
More informationORBE Summary of Benefits
www.wellaway.com ORBE Summary of Benefits www.wellaway.com Summary of Benefits Annual Limit 5,000,000 Coinsurance ORBE 90 ORBE 100 WellAway s share of costs on a covered service Your share of costs on
More informationNATIONAL COST OF OBESITY SEMINAR. Dr. Bill Releford, D.P.M. Founder, Black Barbershop Health Outreach Program
NATIONAL COST OF OBESITY SEMINAR Dr. Bill Releford, D.P.M. Founder, Black Barbershop Health Outreach Program 1 INTRODUCTION According to the Center of Disease Control and Prevention, the American society
More informationOverview of development assistance for health trends
Chapter 1: Overview of development assistance for health trends Since the inception of the first edition of Financing Global Health in 29, IHME has released up-to-date annual estimates of DAH from 199
More informationPARALLELISM AND THE LEGITIMACY GAP 1. Appendix A. Country Information
PARALLELISM AND THE LEGITIMACY GAP 1 Appendix A Country Information PARALLELISM AND THE LEGITIMACY GAP 2 Table A.1 Sample size by country 2006 2008 2010 Austria 2405 2255 0 Belgium 1798 1760 1704 Bulgaria
More informationTUBERCULOSIS AND HIV/AIDS: A STRATEGY FOR THE CONTROL OF A DUAL EPIDEMIC IN THE WHO AFRICAN REGION. Report of the Regional Director.
30 August 2007 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Fifty-seventh session Brazzaville, Republic of Congo, 27 31 August Provisional agenda item 7.8 TUBERCULOSIS AND HIV/AIDS: A STRATEGY FOR THE
More informationItem 4.7. Draft Global Health Sector Strategy for HIV,
Item 4.7 Draft Global Health Sector Strategy for HIV, 2011 2015 Context of EB Discussions Following the request to the Director General in resolution WHA63.19 to submit a WHO HIV/AIDS strategy for 2011
More informationMENTAL HEALTH CARE. OECD HCQI Expert meeting 17 th of May, Rie Fujisawa
MENTAL HEALTH CARE OECD HCQI Expert meeting 17 th of May, 2013 Rie Fujisawa Mental health indicators Any hospital readmissions for patients with schizophrenia Same hospital readmissions for patients with
More informationWho is a migrant? 12/10/2018. HIV and migrants. Heterogeneous groups of persons with different migration drivers
HIV and migrants Julia del Amo has received research grants awarded to her institution from Companies BMS, Gilead, ViiV and epidemiology teaching fees from ViiV, Gilead and MSD Dr Julia del Amo National
More informationPROJECT INFORMATION DOCUMENT (PID) CONCEPT STAGE Report No.: AB4078 Project Name
PROJECT INFORMATION DOCUMENT (PID) CONCEPT STAGE Report No.: AB4078 Project Name HIV/AIDS Project Region AFRICA Sector Health (60%); Other social services (23%); General public administration sector (10%);Central
More informationProgramme of Action for Cancer Therapy PACT. PROGRAMME OF ACTION FOR CANCER THERAPY
Programme of Action for Cancer Therapy PACT pact@iaea.org http://cancer.iaea.org PROGRAMME OF ACTION FOR CANCER THERAPY Since 1980 the IAEA has invested US $202 million to establish safe and effective
More informationGLP in the European Union Ecolabel detergents, GLP and accreditation
GLP in the European Union Ecolabel detergents, GLP and accreditation Maik Schmahl Brussels, 25/03/2010 Chemicals Unit Outline What is GLP? How has it developed? The role of the Member States, the European
More informationCRS Report for Congress
Order Code RS21181 Updated February 23, 2005 CRS Report for Congress Received through the CRS Web HIV/AIDS International Programs: Appropriations, FY2003-FY2006 Raymond W. Copson Specialist in International
More informationAlcohol-related harm in Europe and the WHO policy response
Alcohol-related harm in Europe and the WHO policy response Lars Moller Programme Manager World Health Organization Regional Office for Europe Date of presentation NCD global monitoring framework: alcohol-related
More informationBiology Report. Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis?
Biology Report Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis? Introduction Tuberculosis is a serious disease caused by the bacterium Mycobacterium
More informationEuropean status report on alcohol and health Leadership, awareness and commitment
European status report on alcohol and health 2014 Leadership, awareness and commitment Leadership, awareness and commitment Background Strong leadership from national and local governments is essential
More informationOverview of drug-induced deaths in Europe - What does the data tell us?
Overview of drug-induced deaths in Europe - What does the data tell us? João Matias, Isabelle Giraudon, Julián Vicente EMCDDA expert group on the key-indicator Drug-related deaths and mortality among drug
More informationCountry Length Discount Travel Period Anguilla All 20% off 08/24/11 12/15/11 Antigua All 20% off 08/24/11 12/15/11 Argentina All 20% off 08/24/11
Country Length Discount Travel Period Anguilla All 20% off 08/24/11 12/15/11 Antigua All 20% off 08/24/11 12/15/11 Argentina All 20% off 08/24/11 12/15/11 Aruba All 20% off 08/24/11 12/15/11 Australia
More informationInequalities in health: challenges and opportunities in Europe Dr Zsuzsanna Jakab WHO Regional Director for Europe
Inequalities in health: challenges and opportunities in Europe Dr Zsuzsanna Jakab WHO Regional Director for Europe 21st Congress of the European Association of Dental Public Health 1 October 2016 Budapest
More information1. The World Bank-GAVI Partnership and the Purpose of the Review
1. The World Bank-GAVI Partnership and the Purpose of the Review 1.1 The new World Bank Group strategy makes a strong case for an expanded World Bank Group role in global and regional dialogue and collective
More informationGeneral Assembly. United Nations A/65/L.27. Global health and foreign policy. Distr.: Limited 1 December Original: English
United Nations A/65/L.27 General Assembly Distr.: Limited 1 December 2010 Original: English Sixty-fifth session Agenda item 124 Global health and foreign policy Andorra, Argentina, Australia, Belgium,
More informationGlobal Fund experience on financing the fight against AIDS, tuberculosis and malaria History and lessons learnt Hearings at WHO GCM/NCD working group
Global Fund experience on financing the fight against AIDS, tuberculosis and malaria History and lessons learnt Hearings at WHO GCM/NCD working group 6 May 2015 Geneva Frederic Goyet, External Relations
More informationThe Global Fund & UNICEF Partnership
The Global Fund & UNICEF Partnership Prof Michel D. Kazatchkine Executive Director UNICEF Executive Board February 9 th, 2011 The Global Fund Millennium Development Goals 1. Eradicate extreme poverty and
More informationNumber of people receiving ARV therapy in developing and transitional countries by region,
Progress in numbers The last six months have seen dramatic progress toward the 3 by 5 target. Between June and, the number of people receiving antiretroviral (ARV) therapy in developing and transitional
More informationTHE Price of a Pandemic 2017
THE Price of a Pandemic 2017 From 2000-2015: 33 million people died because of TB at a global economic cost of $617bn This report was produced the Global TB Caucus, an international network of over 2,000
More informationThe Current Status of Cardiac Electrophysiology in ESC Member Countries J. Brugada, P. Vardas, C. Wolpert
Albania. Algeria. Armenia. Austria. Belarus. Belgium. Bosnia & Herzegovina. Bulgaria. Croatia. Cyprus. Czech Republic Denmark. Egypt. Estonia. Finland. Former Yugoslav Republic of Macedonia. France. Georgia.
More informationThe Economics of Tobacco Control and Tobacco Taxation: Challenges & Opportunities for a Tobacco Free Turkey
The Economics of Tobacco Control and Tobacco Taxation: Challenges & Opportunities for a Tobacco Free Turkey Ayda A. Yürekli, WHO, on behalf of author team Ankara, December 23, 2010 With funding from the
More informationFinancing the Response to HIV/AIDS in Low and Middle Income Countries: Funding for HIV/AIDS from the G7 and the European Commission
Financing the Response to HIV/AIDS in Low and Middle Income Countries: Funding for HIV/AIDS from the G7 and the European Commission july 2005 Jennifer Kates Kaiser Family Foundation FINANCING THE RESPONSE
More informationThe power of innovation to save lives
Innovative Finance The power of innovation to save lives May 2013 The challenge Life or death for a young child too often depends on whether he is born in a country where vaccines are available or not.
More informationAIDS Funding Landscape in Asia and the Pacific
Agenda 3: Country experiences and plans towards sustainable AIDS financing AIDS Funding Landscape in Asia and the Pacific J.V.R. Prasada Rao United Nations Secretary-General s Special Envoy for AIDS in
More informationRequest for Letters of Intent. International Development of H5N1 Influenza Vaccines
Request for Letters of Intent International Development of H5N1 Influenza Vaccines The World Health Organization (WHO) intends to provide funding to developing (1) country vaccine manufacturers to develop
More informationFOURIER STUDY GREYLOCK PRESS: CTS PRODUCT SAMPLE - FOURIER YES. Did the study achieve its main objective?
FOURIER STUDY Did the study achieve its main objective? 2 15% 1 5% 9.8% YES FOURIER compared Repatha with placebo in patients who were taking a statin and had hardening or narrowing of the arteries and
More informationWHO global response to salt reduction strategies
WHO global response to salt reduction strategies Dr Godfrey C Xuereb Team Leader Population-based Prevention Team SPP Unit Prevention of Noncommunicable Diseases Department The World Health Organization
More informationAccess to treatment and disease burden
Access to treatment and disease burden Robert Flisiak Department of Infectious Diseases and Hepatology Medical University in Białystok, Poland Moulin de Vernègues, 27-29 August 2015 Disclosures Advisor
More informationJoint Programming in Neurodegenerative Disease Research (JPND)
Joint Programming in Neurodegenerative Disease Research (JPND) Building Alliances and Collaborations Prof. Philippe Amouyel, MD, PhD JPND Chair France Disclosure CEO of Fondation Plan Alzheimer Conference
More information